☆ 4.7 Article

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

CANCER CELL INTERNATIONAL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma

Li-Gong Lu et al.

Summary: In hepatocellular carcinoma (HCC), PD-L1(+) host macrophages are a major cellular source of PD-L1 in tumors, displaying a glycolytic phenotype and producing antitumor IL-12p70. The regulation of these macrophages involves fibronectin 1-induced PKM2, controlling both antitumor properties and inflammation-mediated PD-L1 expression. Modulating the context of glycolytic macrophages in HCC tumors may restore their antitumor properties and offer a precise strategy for anticancer therapy.

GUT (2022)

添加到收藏夹

Article Oncology

Hyperthermia promotes exosome secretion by regulating Rab7b while increasing drug sensitivity in adriamycin-resistant breast cancer

Di Xu et al.

Summary: This study investigated the mechanism through which hyperthermia promotes exosome secretion and drug sensitivity in adriamycin-resistant breast cancer. The results showed that hyperthermia suppressed the growth of cancer cells and increased drug sensitivity. It also upregulated certain genes related to longer overall survival in breast cancer patients. Hyperthermia promoted exosome secretion through a small GTPase called Rab7b. These hyperthermia-triggered exosomes can carry antitumor genes to other cells and may enhance the effects of hyperthermia. This study provides new insights into the relationship between therapeutic strategies and exosome biology.

INTERNATIONAL JOURNAL OF HYPERTHERMIA (2022)

添加到收藏夹

Review Oncology

Treatment landscape of triple-negative breast cancer - expanded options, evolving needs

Giampaolo Bianchini et al.

Summary: Recent advances in omics technologies have improved our understanding of the heterogeneity and microenvironment of triple-negative breast cancers (TNBCs), supporting a view of this breast cancer subtype as an ecosystem that encompasses both intrinsic and extrinsic features of cancer cells. The authors of this Review describe the current and upcoming therapeutic landscape of TNBC and discuss how an integrated view of the TNBC ecosystem can provide improved opportunities for tailoring treatment.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

P. Schmid et al.

Summary: The addition of pembrolizumab to neoadjuvant chemotherapy followed by adjuvant pembrolizumab after surgery significantly prolonged event-free survival in patients with early triple-negative breast cancer.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages

Yuan Yin et al.

Summary: This study reveals that colorectal cancer cells can induce macrophage polarization and PD-L1 expression through the release of small extracellular vesicles (sEVs), leading to suppressed CD8(+) T cell activity and increased tumor growth. The miR-21-5p and miR-200a derived from sEVs play key regulatory roles in this process. Inhibiting the secretion of specific sEV-miRNAs from CRC and targeting PD-L1 in TAMs may serve as novel methods for CRC treatment.

ADVANCED SCIENCE (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression

Yan Li et al.

Summary: This review highlights the biological mediators associated with tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) of breast cancer (BRCA), including cancer-associated fibroblasts, endothelial cells, adipocytes, tumor-derived exosomes, extracellular matrix, and other immune cells. Increased infiltration of TAMs and elevated expression of TAM-related genes have been linked to a poor prognosis of BRCA. TAM-targeted therapeutic strategies, such as inhibitors of CSF-1/CSF-1R, CCL2/CCR2, CCL5-CCR5, bisphosphonate, nanoparticle, and exosomal-targeted delivery, have been developed and are currently being tested in intervention trials.

CURRENT MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

Kohei Shitara et al.

Summary: In patients with gastro-oesophageal adenocarcinoma, nivolumab plus chemotherapy has shown superior overall survival compared to chemotherapy alone.

NATURE (2022)

添加到收藏夹

Review Immunology

Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy

Yiru Long et al.

Summary: With programmed death 1/ligand 1 (PD-1/PD-L1) as the cornerstone, anti-PD antibodies have revolutionized immunotherapies for malignancies. However, many patients fail to respond to anti-PD treatment due to resistance or hyperprogression. The study highlights the importance of noncanonical PD-1/PD-L1 expression in various cancers and its impact on the efficacy of anti-PD antibodies.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer

RamaRao Malla et al.

Summary: Tumor-associated macrophages (TAMs) play a major role in immunosuppression in the breast tumor microenvironment (TME). Their infiltration is associated with negative outcomes for cancer patients. This review summarizes the mechanisms and signaling pathways that regulate the immune-suppressive phenotype and expansion of TAMs, and discusses natural compounds and nanotechnology approaches for targeting TAMs in breast cancer management.

LIFE SCIENCES (2022)

添加到收藏夹

Review Cell Biology

Small extracellular vesicles: from promoting pre-metastatic niche formation to therapeutic strategies in breast cancer

Xiaoxiao Chen et al.

Summary: Breast cancer metastasis is a complex process, and breast cancer-derived small extracellular vesicles (sEVs) play a crucial role in the formation of pre-metastatic niches. sEVs contribute to tumor invasion through various mechanisms and can also be used as biomarkers and antimetastatic therapies for breast cancer.

CELL COMMUNICATION AND SIGNALING (2022)

添加到收藏夹

Article Oncology

PD-L1 status in breast cancer: Current view and perspectives

Semir Vranic et al.

Summary: Breast cancer, traditionally considered not highly immunogenic, has been found to exhibit immunogenicity in some cases, particularly in aggressive triple-negative types. However, challenges remain in identifying patients who would benefit from immunotherapy and in analyzing samples accurately for immune cell targets. Explore exploration of checkpoint inhibitors in breast cancer, specifically in PD-L1 testing, is an important aspect of current research.

SEMINARS IN CANCER BIOLOGY (2021)

添加到收藏夹

Article Cell Biology

Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis

Su-jin Yang et al.

Summary: This study reveals that circPSMA1 functions as a tumor promoter in triple-negative breast cancer (TNBC) by acting as a miRNA sponge to absorb miR-637 and regulate Akt1-beta-catenin (cyclin D1) axis. Exosomes from TNBC cells carrying high levels of circPSMA1 can transmit migration and proliferation capacity to recipient cells. High expression of Akt1 and low expression of miR-637 are highly correlated with poor prognosis in TNBC patients with lymph node metastasis.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Review Oncology

Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets

Yiran Liang et al.

SEMINARS IN CANCER BIOLOGY (2020)

添加到收藏夹

Review Oncology

Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice

Sharmilla Devi Jayasingam et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortes et al.

LANCET (2020)

添加到收藏夹

Review Oncology

Isolation and characterization of exosomes for cancer research

Le Zhu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Review Oncology

Triple-negative breast cancer molecular subtyping and treatment progress

Li Yin et al.

BREAST CANCER RESEARCH (2020)

添加到收藏夹

Review Cell Biology

Exosome-Mediated Metastasis: Communication from a Distance

Inbal Wortzel et al.

DEVELOPMENTAL CELL (2019)

添加到收藏夹

Review Cell Biology

Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease

Marcelo A. Mori et al.

CELL METABOLISM (2019)

添加到收藏夹

Review Oncology

Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer

Juliet Richman et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

添加到收藏夹

Review Oncology

The dual functional role of MicroRNA-18a (miR-18a) in cancer development

Kexin Shen et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment

Elham Azizi et al.

CELL (2018)

添加到收藏夹

Article Oncology

Exosome-mediated miR-222 transferring: An insight into NF-κ-mediated breast cancer metastasis

Jiaji Ding et al.

EXPERIMENTAL CELL RESEARCH (2018)

添加到收藏夹

Article Pathology

Clinicopathological correlation of PD-L1 expression in primary and metastatic breast cancer and infiltrating immune cells

Ossama Tawfik et al.

HUMAN PATHOLOGY (2018)

添加到收藏夹

Review Immunology

Regulation and Function of the PD-L1 Checkpoint

Chong Sun et al.

IMMUNITY (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Biogenesis and function of extracellular vesicles in cancer

Maarten P. Bebelman et al.

PHARMACOLOGY & THERAPEUTICS (2018)

添加到收藏夹

Article Oncology

Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation

Genevieve P. Hartley et al.

CANCER IMMUNOLOGY RESEARCH (2018)

添加到收藏夹

Article Oncology

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)

Leora Horn et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Immunology

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity

Vikram R. Juneja et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

添加到收藏夹

Review Immunology

Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization

Eleni Vergadi et al.

JOURNAL OF IMMUNOLOGY (2017)

添加到收藏夹

Article Cell Biology

MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer

Nana Li et al.

CELL DEATH & DISEASE (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis

Shao-Lai Zhou et al.

HEPATOLOGY (2016)

添加到收藏夹

Article Immunology

Gut macrophage phenotype is dependent on the tumor microenvironment in colorectal cancer

Samuel E. Norton et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Tumour exosome integrins determine organotropic metastasis

Ayuko Hoshino et al.

NATURE (2015)

添加到收藏夹

Article Oncology

Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis

Weiying Zhou et al.

CANCER CELL (2014)

添加到收藏夹

Article Immunology

Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation

Jia Xue et al.

IMMUNITY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Thomas Powles et al.

NATURE (2014)

添加到收藏夹

Review Biochemistry & Molecular Biology

Microenvironmental regulation of tumor progression and metastasis

Daniela F. Quail et al.

NATURE MEDICINE (2013)

添加到收藏夹

Review Oncology

Microenvironmental Regulation of Epithelial-Mesenchymal Transitions in Cancer

Dingcheng Gao et al.

CANCER RESEARCH (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature

Qiong-wen Zhang et al.

PLOS ONE (2012)

添加到收藏夹

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase

C Luberto et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.